全文获取类型
收费全文 | 13533篇 |
免费 | 1206篇 |
国内免费 | 1023篇 |
专业分类
耳鼻咽喉 | 60篇 |
儿科学 | 168篇 |
妇产科学 | 141篇 |
基础医学 | 1614篇 |
口腔科学 | 168篇 |
临床医学 | 1712篇 |
内科学 | 1911篇 |
皮肤病学 | 147篇 |
神经病学 | 606篇 |
特种医学 | 434篇 |
外国民族医学 | 3篇 |
外科学 | 1304篇 |
综合类 | 2364篇 |
现状与发展 | 3篇 |
一般理论 | 2篇 |
预防医学 | 1017篇 |
眼科学 | 387篇 |
药学 | 1501篇 |
25篇 | |
中国医学 | 664篇 |
肿瘤学 | 1531篇 |
出版年
2025年 | 3篇 |
2024年 | 162篇 |
2023年 | 245篇 |
2022年 | 546篇 |
2021年 | 635篇 |
2020年 | 556篇 |
2019年 | 481篇 |
2018年 | 443篇 |
2017年 | 405篇 |
2016年 | 419篇 |
2015年 | 626篇 |
2014年 | 691篇 |
2013年 | 615篇 |
2012年 | 872篇 |
2011年 | 934篇 |
2010年 | 524篇 |
2009年 | 420篇 |
2008年 | 559篇 |
2007年 | 735篇 |
2006年 | 659篇 |
2005年 | 616篇 |
2004年 | 583篇 |
2003年 | 644篇 |
2002年 | 587篇 |
2001年 | 467篇 |
2000年 | 409篇 |
1999年 | 354篇 |
1998年 | 203篇 |
1997年 | 219篇 |
1996年 | 154篇 |
1995年 | 176篇 |
1994年 | 141篇 |
1993年 | 85篇 |
1992年 | 120篇 |
1991年 | 87篇 |
1990年 | 63篇 |
1989年 | 61篇 |
1988年 | 66篇 |
1987年 | 49篇 |
1986年 | 42篇 |
1985年 | 34篇 |
1984年 | 22篇 |
1983年 | 12篇 |
1982年 | 8篇 |
1981年 | 9篇 |
1980年 | 10篇 |
1979年 | 5篇 |
1978年 | 3篇 |
1972年 | 1篇 |
1963年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
BACKGROUND: As a special source of stem cells, dental pulp stem cells (DPSCs) make much progress in the development of tissue engineering field due to their high proliferation and self-renewal ability. In the certain conditions DPSCs can be induced to differentiate into a variety of specialized tissue cells, providing a new way for tissue engineering development. OBJECTIVE: To review the main progress in the DPSCs biological characteristics, original source, isolation method, and its related application in tissue engineering research. METHODS: “Dental pulp stem cell, differentiation, regenerative medicine, tissue engineering” in English and Chinese were termed as the keywords to search relevant articles about DPSCs and tissue engineering published from 2005 to 2017 in PubMed, Medline, WanFang, and CNKI databases. After removal of repetitive or irrelevant articles, 66 articles were finally reviewed. RESULTS AND CONCLUSION: With the development of tissue engineering and regenerative medicine, the effective combination of DPSCs and tissue engineering scaffolds have be further achieved. Recent studies on DPSCs focus on the properties of DPSCs differentiating into odontoblasts and osteocytes/osteoblasts and on the potential of nerve repair, vascular remodeling, corneal reconstruction and chondrogenic differentiation. © 2018, Journal of Clinical Rehabilitative Tissue Engineering Research. All rights reserved. 相似文献
23.
24.
Time-average albumin predicts the long-term prognosis of IgA nephropathy patients achieved remission
Yuan Yanhong Wang Qin Zhang Minfang Cao Liou Che Xiajing Tian Lei Qi Chaojun Shao Xinghua Ni Zhaohui Mou Shan. 《中华肾脏病杂志》2015,31(2):102-108
Objective To clarify the long-term renal prognosis and related risk factors of progression for IgA nephropathy (IgAN) patients who achieved remission under current therapy. To identify the target value of the serum albumin level for Chinese patients with IgAN. Methods The patients with biopsy-proven primary IgAN in Nephrology Department of Renji Hospital in Shanghai were studied.The survival of renal and the relationships between clinical parameters and renal outcome were assessed. Results A total of 369 patients between Jan 2005 and Dec 2010 were included with a median follow-up time of 49.0 (38.0-65.8) months. All the subjects had achieved a complete remission (CR) or partial remission (PR) following six months’ therapy after diagnosis. Progressive renal disease had occurred in 61 cases at the end of follow-up. Three variables had a significant independent effect on renal outcome in patients achieving remission under current therapy regimen for IgAN, including time-average serum creatinine (TA-Scr) [HR(95%CI): 1.03(1.01-1.04)], time-average serum albumin (TA-Alb) [HR(95%CI): 0.83 (0.69-0.99)], and eGFR ratio within one year [HR(95%CI): 0.00(0.00-0.01)]. By multivariate Cox analyses, each 1 g/L drop of TA-Alb was related with 17.2% increase in the risk of renal progression. The ROC curve indicated that combination of serum albumin at baseline and during a long-term had a more significant value in prediction of renal outcome than independent predictor alone. By Kaplan-Meier analyses, patients with TA-Alb﹤38 g/L had a 10.4 fold sincreased risk of progressive disease compared with that of TA-Alb﹥38 g/L. Conclusions IgAN patients with lower eGFR ratio, higher TA-Scr and lower TA-Alb would progress to ESRD more quickly, and serum albumin during follow-up is important for predicting IgAN progression. 相似文献
25.
Chen Longmao Shao Ziqiang Lei Wangrui Xu Yan Liu Shuang Zhang Min Wang Shicong Wen Xinwen Yu Dahua Yuan Kai 《Brain imaging and behavior》2022,16(2):672-679
Brain Imaging and Behavior - To date, our understanding of the role of abnormal hippocampal volume in imaging studies of insomnia disorders (ID) has remained in apparent contradiction. Given that... 相似文献
26.
Shao Xiexiang Sui Wenyuan Deng Yaolong Yang Jingfan Chen Jian Yang Junlin 《European spine journal》2022,31(4):996-1005
European Spine Journal - To introduce and evaluate our lowest instrumented vertebra (LIV) selection criteria for Lenke type 5/6 adolescent idiopathic scoliosis (AIS) patients with de-rotation... 相似文献
27.
28.
Liu Ping Zhang Shuying Jiang Lijuan Ma Jinhong Shao Xiaonan 《Clinical and experimental nephrology》2022,26(2):113-121
Clinical and Experimental Nephrology - To explore the relationship between low-density lipoprotein cholesterol (LDL-C) level and infection risk in elderly stage 5 kidney disease (CKD) patients.... 相似文献
29.
30.
目的 探讨结外NK/T细胞淋巴瘤鼻型(ENKTL)患者治疗前B症状与血浆EBV‐DNA拷贝数和血清细胞因子水平的相关关系,并分析其机制和预后价值。方法 回顾性分析资料齐全的173例患者,其中男性116例,女性57例,中位年龄43岁(4~71岁)。Ann Arbor分期Ⅰ‐Ⅱ期126例,Ⅲ‐Ⅳ期47例。肿瘤原发部位包括鼻腔(100例)、非鼻腔上呼吸消化道(34例)和上呼吸消化道以外(39例)。治疗前有和无B症状者分别为91例和82例。按照血浆EBV‐DNA拷贝数的高低分为阴性组36例、低载量(<104 copies/ml)组73例和高载量(≥104 copies/ml)组64例。检测的血清细胞因子包括IFN‐γ、IL‐2、IL‐4、IL‐6、IL‐10和TNF‐α。相关性分析采用Cochran‐Armitage趋势检验和Spearman相关性分析,采用Cox回归风险模型进行单因素分析评估预后影响因素并用Kaplan‐Meier法绘制生存曲线。结果 B症状及发热的发生与血浆EBV‐DNA拷贝水平的增加呈显著一致的趋势,发生B症状的患者其血清IFN‐γ、IL‐6和IL‐10的水平均高于无B症状组(P均<0.001)。血清IFN‐γ、IL‐6和IL‐10水平也均与血浆EBV‐DNA拷贝数呈正相关。B症状的发生与ENKTL患者的高危临床特征相关,包括晚期、原发肿瘤局部侵犯、区域淋巴结累及和治疗前LDH升高。单因素生存分析显示,Ann Arbor分期、B症状、血浆EBV‐DNA及上述血清细胞因子均为OS和PFS的影响因素(P均<0.05)。然而,多因素分析并未显示B症状对生存的独立预后价值。结论 ENKTL患者B症状的发生与EBV‐DNA拷贝水平和细胞因子的增高有关,这些指标也是影响ENKTL患者预后的重要因素。 相似文献